메뉴 건너뛰기




Volumn 36, Issue SUPPL. 83, 2009, Pages 78-80

Criteria, frequency, and duration of clinical remission in psoriatic arthritis patients with peripheral involvement requiring second-line drugs

Author keywords

Anti tumor necrosis factor; Disease activity; Disease modifying antirheumatic drugs; Psoriatic arthritis; Remission; Rheumatoid arthritis

Indexed keywords

CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; TUMOR NECROSIS FACTOR INHIBITOR; ANTIRHEUMATIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

EID: 70349907640     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090234     Document Type: Conference Paper
Times cited : (16)

References (17)
  • 2
  • 4
    • 0345099477 scopus 로고    scopus 로고
    • A prospective, clinical and radiological study of early psoriatic arthritis: An early synovitis clinic experience
    • DOI 10.1093/rheumatology/keg384
    • Kane D, Stafford L, Bresnihan B, Fitzgerald O. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology 2003;42:1460-1468 (Pubitemid 37508919)
    • (2003) Rheumatology , vol.42 , Issue.12 , pp. 1460-1468
    • Kane, D.1    Stafford, L.2    Bresniham, B.3    Fitzgerard, O.4
  • 5
    • 0041826789 scopus 로고    scopus 로고
    • Effectiveness of psoriatic arthritis therapies
    • Gladman DD. Effectiveness of psoriatic arthritis therapies. Semin Arthritis Rheum 2003;33:29-37.
    • (2003) Semin Arthritis Rheum , vol.33 , pp. 29-37
    • Gladman, D.D.1
  • 6
    • 14244269340 scopus 로고    scopus 로고
    • Psoriatic arthritis therapy: NSAIDs and traditional DMARDs
    • DOI 10.1136/ard.2004.030783
    • Nash P, Clegg DO. Psoriatic arthritis therapy: NSAIDs and traditional DMARDs. Ann Rheum Dis 2005;64:ii74-ii77. (Pubitemid 40288528)
    • (2005) Annals of the Rheumatic Diseases , vol.64 , Issue.SUPPL. 2
    • Nash, P.1    Clegg, D.O.2
  • 7
    • 0030753980 scopus 로고    scopus 로고
    • Psoriatic arthritis: A quantitative overview of therapeutic options
    • The Psoriatic Arthritis Meta-Analysis Study Group
    • Jones G, Crotty M, Brooks P. Psoriatic arthritis: a quantitative overview of therapeutic options. The Psoriatic Arthritis Meta-Analysis Study Group. Br J Rheumatol 1997;36:95-99
    • (1997) Br J Rheumatol , vol.36 , pp. 95-99
    • Jones, G.1    Crotty, M.2    Brooks, P.3
  • 8
    • 14244268696 scopus 로고    scopus 로고
    • Psoriatic arthritis treatment: Biological response modifiers
    • Mease PJ, Antoni CE. Psoriatic arthritis treatment: biological response modifiers. Ann Rheum Dis 2005;64 Suppl II:ii78-ii82.
    • (2005) Ann Rheum Dis , vol.64 , Issue.SUPPL. II
    • Mease, P.J.1    Antoni, C.E.2
  • 9
    • 2642558895 scopus 로고    scopus 로고
    • Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: A multinational, double-blind, randomized, placebo-controlled clinical trial
    • DOI 10.1002/art.20253
    • Kaltwasser JP, Nash P, Gladman DD, et al. Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial. Arthritis Rheum 2004;50:1939-1950 (Pubitemid 38725106)
    • (2004) Arthritis and Rheumatism , vol.50 , Issue.6 , pp. 1939-1950
    • Kaltwasser, J.P.1    Nash, P.2    Gladman, D.3    Rosen, C.F.4    Behrens, F.5    Jones, P.6    Wollenhaupt, J.7    Falk, F.G.8    Mease, P.9
  • 10
    • 14244268696 scopus 로고    scopus 로고
    • Psoriatic arthritis treatment: Biological response modifiers
    • Mease PJ, Antoni CE. Psoriatic arthritis treatment: biological response modifiers. Ann Rheum Dis 2005;64:78-82.
    • (2005) Ann Rheum Dis , vol.64 , pp. 78-82
    • Mease, P.J.1    Antoni, C.E.2
  • 11
    • 33745801586 scopus 로고    scopus 로고
    • Therapies for peripheral joint disease in psoriatic arthritis
    • Soriano ER, McHugh NJ. Therapies for peripheral joint disease in psoriatic arthritis. J Rheumatol 2006;33:1422-1430
    • (2006) J Rheumatol , vol.33 , pp. 1422-1430
    • Soriano, E.R.1    McHugh, N.J.2
  • 13
    • 33644861049 scopus 로고    scopus 로고
    • Efficacy, effectiveness and safety of etanercept in monotherapy for refractory psoriatic arthritis: A 26-week observational study
    • DOI 10.1093/rheumatology/kei153
    • de Vlam K, Lories RJ. Efficacy, effectiveness and safety of etanercept in monotherapy for refractory psoriatic arthritis: a 26-week observational study. Rheumatology 2006;45:321-324 (Pubitemid 43372848)
    • (2006) Rheumatology , vol.45 , Issue.3 , pp. 321-324
    • De Vlam, K.1    Lories, R.J.U.2
  • 14
    • 0019407824 scopus 로고
    • Preliminary criteria for clinical remission in rheumatoid arthritis
    • DOI 10.1002/art.1780241012
    • Pinals RS, Masi AT, Larsen RA. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981;24:1308-1315 (Pubitemid 11022943)
    • (1981) Arthritis and Rheumatism , vol.24 , Issue.10 , pp. 1308-1315
    • Pinals, R.S.1    Masi, A.T.2    Larsen, R.A.3
  • 15
    • 0023945481 scopus 로고
    • The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
    • Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324
    • (1988) Arthritis Rheum , vol.31 , pp. 315-324
    • Arnett, F.C.1    Edworthy, S.M.2    Bloch, D.A.3
  • 17
    • 0021272107 scopus 로고
    • Evaluation of diagnostic criteria for ankylosing spondylitis. a proposal for modification of the New York criteria
    • Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-368 (Pubitemid 14134775)
    • (1984) Arthritis and Rheumatism , vol.27 , Issue.4 , pp. 361-368
    • Van Der Linden, S.1    Valkenburg, H.A.2    Cats, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.